As of 2025-07-16, the Intrinsic Value of PMV Pharmaceuticals Inc (PMVP) is -5.86 USD. This PMVP valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.33 USD, the upside of PMV Pharmaceuticals Inc is -540.53%.
Based on its market price of 1.33 USD and our intrinsic valuation, PMV Pharmaceuticals Inc (PMVP) is overvalued by 540.53%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -5.86 - -5.86 | -5.86 | -540.53% |
| P/E | (16.05) - (31.05) | (25.02) | -1981.0% |
| DDM - Stable | (5.84) - (13.86) | (9.85) | -840.7% |
| DDM - Multi | (4.49) - (8.64) | (5.94) | -546.9% |
| Market Cap (mil) | 69.09 |
| Beta | 0.49 |
| Outstanding shares (mil) | 51.95 |
| Enterprise Value (mil) | 17.75 |
| Market risk premium | 4.60% |
| Cost of Equity | 14.82% |
| Cost of Debt | 5.00% |
| WACC | 9.91% |